Rocket Companies: The Value Case Grows Stronger, Despite Stubborn Mortgage Rates

Rocket Companies remains rated a Buy despite regulatory headwinds, higher mortgage rates, and a 20% share price decline since March. Q1 revenue rose 126% year over year with beats on both revenue and adjusted EBITDA, but management issued cautious Q2 guidance. EPS is still expected to grow more than 160% in 2024, though recent estimate revisions and out-year forecasts are trending lower.

Analysis

RKT is behaving like a leveraged call option on the mortgage refi/transaction cycle, but the market is increasingly paying for the optionality without confidence in the duration. The first-order benefit of a strong quarter is obvious; the second-order issue is that the earnings reset is being driven as much by acquisition accounting and mix shift as by durable organic loan growth, which makes forward EPS less reliable than the headline growth rate suggests. In other words, the multiple can expand on near-term beats, but the quality of those beats matters more when rates stay higher for longer.

The biggest winner if mortgage rates stay elevated is not RKT’s core origination franchise but the competition around it: banks and depositories with stronger balance sheets can keep capturing customer relationships while waiting for a lower-rate window, whereas RKT’s economics are more cyclical and more sensitive to volume compression. A weaker housing turnover environment also creates a lagged benefit for servicing and ancillary revenues, but that tends to offset only part of the damage from lower new-loan formation. If rate cuts are delayed, the likely outcome is not a collapse in the business but a prolonged margin grind that keeps estimate revisions drifting down.

The key catalyst over the next 1-3 months is guidance credibility, not the last quarter’s outperformance. If management can show stable pull-through, recapture rates, and expense discipline into Q2, the stock can recover some of the post-March drawdown; if not, the market will likely re-rate the name toward a lower-quality cyclical lender despite the buy rating. Regulatory noise is a secondary, but important, overhang because it raises the discount rate on any M&A-led earnings lift: acquisitions help EPS in the near term, but they also increase scrutiny if consumer-facing economics weaken.

The contrarian view is that the selloff may be partially overdone if investors are extrapolating the guidance miss rather than the asset-light earnings power in a normalization scenario. What the market may be missing is that RKT needs only modest rate relief for operating leverage to reassert itself sharply; the asymmetry is better in 6-12 months than in the next 1-2 quarters. Still, until rate expectations turn decisively lower, this is more of a trading vehicle than a clean fundamental compounder.

Key Decisions for Investors

• Trade idea: buy RKT on weakness only if it re-tests recent support after guidance-related selling; use a 3-6 month horizon and target a rebound to the pre-March valuation band, but keep a tight stop because the name remains rate-beta sensitive.
• Pair trade: long RKT / short a diversified bank ETF or a depository-heavy peer basket for a 1-2 quarter view on mortgage-rate normalization; the thesis is that RKT’s operating leverage is more convex if rates roll over, while banks have less upside from a cyclical turn.
• Options: sell downside put spreads in RKT only if implied volatility stays elevated after the next earnings-related move; this expresses a view that the stock is already pricing a lot of bad news, but cap risk because estimate revisions are still drifting lower.
• If you want cleaner risk/reward, wait for confirmation on Q2 origination volumes before adding exposure; a stable volume print would be a stronger signal than EPS growth because it would validate the earnings quality behind the acquisition-driven lift.